U.S. Office REITs Stock News

NYSE:BXP
NYSE:BXPOffice REITs

BXP Headquarters Shift Highlights Tenant Strategy And Washington DC Portfolio Choices

BXP (NYSE:BXP) is relocating its regional headquarters to make room for major tenant the Washington Commanders in Foggy Bottom. The company is moving into a newly renovated downtown Washington, DC office building as part of this shift. The relocation aligns with recent leasing activity and capital deployment in the DC market. For investors watching NYSE:BXP, this move ties directly to how the company is using its portfolio to support active leasing and tenant relationships. The stock last...
NasdaqCM:INO
NasdaqCM:INOBiotechs

Is Inovio (INO) Turning Fresh DNA Medicine Data Into a More Coherent Investment Story?

Inovio Pharmaceuticals recently announced plans to release its Q1 2026 earnings after market close on May 13, 2026, alongside a conference call and upcoming scientific presentations on its DNA medicine pipeline for HPV-related diseases, cancer, and infectious diseases. Investor attention has intensified as Inovio’s DNA vaccine and gene transfer programs gain visibility, supported by significant institutional ownership and new clinical data disclosures on candidates such as INO-3107 and its...
NasdaqCM:KG
NasdaqCM:KGInsurance

Kestrel Group (KG) Q4 Loss Of US$2.13 EPS Challenges Recent Profitability Narrative

Kestrel Group (KG) has wrapped up FY 2025 with fourth quarter revenue of US$10.2 million and a basic EPS loss of US$2.13, alongside net income from ongoing operations of a US$16.5 million loss and a US$1.4 million loss from discontinued operations. Over recent periods the company has seen quarterly revenue move from US$1.22 million in Q4 2024 to US$17.4 million in Q3 2025 and then US$10.2 million in Q4 2025. Basic EPS shifted from a small profit of US$0.02 in Q4 2024 to a sizeable profit of...
NasdaqGS:PAX
NasdaqGS:PAXCapital Markets

A Look At Patria Investments (PAX) Valuation After Recent Share Price Weakness

Why Patria Investments (PAX) is on investors’ radar today Patria Investments (PAX) has drawn attention after recent trading left the stock around $12.04, with returns showing mixed signals over the past week, month and past 3 months. See our latest analysis for Patria Investments. The recent 6.8% one day share price decline and 24.4% year to date share price loss contrast with a 9.8% one year total shareholder return. This suggests that recent momentum has faded even as income and past...
NYSE:KFY
NYSE:KFYProfessional Services

Korn Ferry Repeated Forbes Honor And What It May Mean For Valuation

Korn Ferry (NYSE:KFY) has been named America’s Best Executive Recruiter by Forbes Magazine for the ninth time in ten years. The recognition highlights Korn Ferry’s position among the top professional search firms in the United States. Korn Ferry’s latest recognition comes as the stock trades at $67.14, with a 3.8% return over the past year and a 51.2% return over three years. The company’s track record in executive recruitment, reflected in this recurring award, helps frame NYSE:KFY as a...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Why Kodiak AI (KDK) Is Up 7.3% After $100M Raise And Defense Logistics Expansion

In early May 2026, Kodiak AI, Inc. closed a roughly US$100,000,000 private placement and reported first-quarter 2026 results showing higher sales and a move to net income, while advancing autonomous freight operations in the U.S., launching a Canadian timber pilot, and expanding into defense through a collaboration with General Dynamics Land Systems. Taken together, these moves highlight Kodiak’s push to apply its Kodiak Driver platform across long-haul trucking, industrial logistics and...
NYSE:WKC
NYSE:WKCOil and Gas

Is World Kinect (WKC) Still Attractive After Recent 30 Day Share Price Jump

For readers wondering whether World Kinect is priced attractively right now or if the market has already factored in its potential, this article focuses squarely on what the current share price might be implying about value. World Kinect shares last closed at US$26.90, with returns of 14.1% over the past 30 days and 11.5% year to date, alongside a 4.5% return over the past year and 27.1% over three years, compared with a 5.3% decline across five years. Recent price moves sit against a...
NYSE:FUN
NYSE:FUNHospitality

Six Flags Leadership Shakeup Meets Strong Valuation And Momentum Signals

Six Flags Entertainment (NYSE:FUN) has announced several senior leadership changes, including a new Chief Marketing Officer from Carnival Cruise Line. The company has appointed a new Chief Legal and Compliance Officer joining from Dentons. An Interim Chief Financial Officer has stepped in following the resignation of the previous CFO. These appointments come as Six Flags Entertainment trades around $22.76, with recent moves in the stock that include a 21.2% return over the past week and...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

MGE Energy’s $250m Equity Raise And What It Means For Investors

MGE Energy (NasdaqGS:MGEE) has launched a $250 million equity offering via an underwritten public offering and forward sale agreements. The company plans to use the net proceeds for general corporate purposes, including potential investments and balance sheet needs. The offering structure combines immediate share issuance with future share delivery through forward sale counterparties. MGE Energy operates as a regulated utility, so access to capital markets is central to funding projects and...
NYSE:LBRT
NYSE:LBRTEnergy Services

Liberty Energy Expands Beyond Oilfield Services With $505m Bergen Agreements

Liberty Energy (NYSE:LBRT) has entered into $505 million multi-year supply agreements with Bergen Engines. The contracts cover power generation equipment for future data center and distributed power projects. These agreements mark an expansion of Liberty Energy's activity beyond its traditional oilfield services focus. Liberty Energy, trading at $31.68, has seen strong share price performance, with the stock up 67.8% year to date and 172.0% over the past year. The company has also delivered...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Is It Too Late To Consider Corvus Pharmaceuticals (CRVS) After A 335% One Year Surge?

If you are wondering whether Corvus Pharmaceuticals stock still offers value after a big run, the next sections break down what the current price might imply about expectations. The stock recently closed at US$14.59, with a 1 year return of 335.5% and a year to date return of 99.3%, alongside a 4.0% decline over the last 7 days and a 1.7% gain over the past 30 days. Recent news coverage has focused on Corvus Pharmaceuticals within the context of its sector and ongoing product development...
NYSE:CBL
NYSE:CBLRetail REITs

Is It Too Late To Look At CBL & Associates Properties (CBL) After A 92% Year?

Wondering if CBL & Associates Properties at around US$43.95 is still good value after its recent run, or if most of the easy gains are already behind it. The stock has had a strong stretch, with a 19.0% return year to date and 91.9% over the last year, although the past week showed a 2.4% decline after a 7.2% gain in the last 30 days. Recent coverage has focused on CBL & Associates Properties as a retail focused real estate investment trust, with investors paying attention to how it is...
NasdaqGS:TWFG
NasdaqGS:TWFGInsurance

Assessing TWFG (TWFG) Valuation After Mixed Recent Share Price Performance

What TWFG’s Recent Share Moves Signal for Investors TWFG (TWFG) has drawn investor attention after recent share price moves, with the stock showing mixed short term performance, modest gains over the past month, but a sharper decline over the past 3 months and year. See our latest analysis for TWFG. At a share price of $19.35, TWFG’s recent 1 day and 7 day share price returns have been positive, but the 90 day share price return and 1 year total shareholder return both point to fading...
NYSE:HP
NYSE:HPEnergy Services

Is Helmerich & Payne (HP) Still Attractively Priced After Its 110% One Year Surge?

If you are wondering whether Helmerich & Payne at around US$36.90 is still offering value after a strong run, this breakdown will help you see how the current price stacks up against several valuation checks. The stock has had a mixed short term, with an 8.6% decline over the last 7 days, a 2.8% gain over the past 30 days, and returns of 23.2% year to date and 110.2% over the last year. Recent coverage has focused on Helmerich & Payne in the context of ongoing interest in energy services...
NYSE:MSA
NYSE:MSACommercial Services

MSA Safety Buys Autronica To Broaden Detection Reach And Earnings Potential

MSA Safety (NYSE:MSA) has signed a definitive agreement to acquire Norway based Autronica Fire & Security. The deal values Autronica at about $550–$555 million. The acquisition adds depth in fire and gas detection for petrochemical, oil and gas, maritime, and wider industrial markets. For investors tracking NYSE:MSA, this move comes with the stock around $171.9 and a value score of 4, alongside a 10.5% return over the past year and 25.6% over three years. The company has also posted a 6.0%...
NYSE:VIRT
NYSE:VIRTCapital Markets

Virtu Financial Links Market Making To Zerohash Digital Asset Liquidity

Virtu Financial (NYSE:VIRT) has joined zerohash's liquidity ecosystem as a market-making partner. The company is providing liquidity across zerohash's central limit order book and request for quote systems. The move connects Virtu's market-making capabilities with a growing digital asset infrastructure provider. For you as an investor, this move ties a traditional electronic market maker directly into a digital asset venue. Virtu Financial focuses on market making and trade execution across...
NYSE:FG
NYSE:FGInsurance

Is F&G Annuities & Life (FG) Priced Fairly After Recent Share Price Rebound?

If you are wondering whether F&G Annuities & Life is attractively priced or just looks cheap on the surface, its recent share performance gives a few clues worth unpacking. The stock last closed at US$27.08, with a 10.1% gain over the past month but a 9.0% decline over the last year and a 9.9% decline year to date, which may leave you questioning whether sentiment or fundamentals are in the driving seat. Recent coverage of F&G Annuities & Life has focused on its position as a listed insurer...
NasdaqGS:DOX
NasdaqGS:DOXIT

Does Amdocs (DOX) Offer Opportunity After A 27.6% One-Year Share Price Decline

If you are wondering whether Amdocs stock is starting to look like value or a value trap, the current share price puts that question front and center. The stock closed at US$65.14 recently, with returns of 0.7% over 7 days, a 1.9% decline over 30 days, an 18.7% decline year to date and a 27.6% decline over the last year. This naturally raises questions about how the market is reassessing both growth potential and risk. Recent coverage has focused on how Amdocs fits into broader shifts in...
NYSE:AGRO
NYSE:AGROFood

Is Adecoagro (AGRO) Attractive After A 72% Rally And Recent Pullback?

Wondering if Adecoagro's recent share price puts it at a bargain or already reflects its strengths? This article breaks down what the current valuation is really telling you. The stock last closed at US$13.37, with a 72.3% return year to date and a 59.0% return over the past year. This is set against shorter term pullbacks of 5.1% over 7 days and 11.0% over 30 days that may signal shifting sentiment around risk and reward. Recent news around global food supply resilience, agricultural input...
NasdaqGS:MXL
NasdaqGS:MXLSemiconductor

Is It Too Late To Consider MaxLinear (MXL) After A 6x One-Year Share Price Jump?

If you are wondering whether MaxLinear's recent share price move has left the stock looking expensive or still potentially interesting, the valuation story is where your attention should be. The stock last closed at US$82.37, with returns of 16.4% over 7 days, 347.4% over 30 days, 345.0% year to date and a very large 1 year gain that is more than 6x. These moves sit against a backdrop of ongoing interest in semiconductor stocks, with investors watching closely for updates on demand for...
NasdaqCM:TNYA
NasdaqCM:TNYABiotechs

Tenaya Therapeutics (TNYA) Valuation Check As TN-401 Gene Therapy Data Approaches ASGCT 2026

Why the upcoming TN-401 data matters for Tenaya Therapeutics stock Tenaya Therapeutics (TNYA) is drawing attention as investors look ahead to new clinical safety and efficacy data for TN-401, its gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, at the ASGCT 2026 meeting. This late breaking oral presentation, together with additional abstracts on Tenaya’s gene therapy and gene editing programs, gives you fresh information to evaluate the company’s pipeline...
NYSE:AGBK
NYSE:AGBKBanks

AGI ESOP Shelf Registration Raises Questions On Dilution And Dividends

AGI (NYSE:AGBK) has filed a substantial Shelf Registration tied to an Employee Stock Ownership Plan for a large block of Class A common shares. The filing outlines a framework for issuing ESOP related shares over time, which can influence the company’s capital structure and employee ownership levels. AGI, trading at $7.39, has had mixed recent performance, with the stock up 4.2% over the past week and 9.5% over the past month, while showing a 31.3% decline year to date. The new ESOP related...
NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Zai Lab Weighs New Pipeline Data And KarXT Launch Against Revenue Pressures

Zai Lab (NasdaqGM:ZLAB) reported new clinical data from its global oncology and immunology pipeline, including intracranial response data for zoci in small cell lung cancer. The company is preparing to launch KarXT in China for schizophrenia in the next quarter. Management highlighted these pipeline and launch updates while also flagging near term revenue pressure. Zai Lab focuses on developing and commercializing medicines in oncology and immunology, as well as central nervous system...
NasdaqGS:DGII
NasdaqGS:DGIICommunications

Digi International Reshapes IoT Model As ARR Jumps 50%

Digi International acquired Jolt Software and Particle Industries, reshaping its Internet of Things (IoT) offering. The company reports that these deals, combined with organic growth, have lifted annual recurring revenue (ARR) by 50%. Management highlights strong cash flow as a key support for integrating these acquisitions into the existing business. Digi International (NasdaqGS:DGII) is drawing fresh attention as it leans harder into IoT platforms and recurring software revenue. The stock...